logo

For the Inventor, By the Inventor

Ellicott City, MD, United States of America

Victor L Serebruany

This inventor holds 5 USPTO granted patents and 5 published patent applications. Top assignees: Heartdrug Research, L.l.c., Other. Active years: 2001-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor L Serebruany. Retrieved from https://idiyas.com/inventor/victor-l-serebruany

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Ellicott City, MD (US) (2001 - 2003)
  • Elicott City, MD (US) (2010 - 2012)

Company Filing History:

goldMedal4 out of 4 
 
Heartdrug Research, L.l.c.
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 2001-2012

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8232295 - Treating vascular events with statins by inhibiting PAR-1 and PAR-4 (2012-07-31),
2. 7842716 - Treating vascular events with statins by inhibiting PAR-1 and PAR-4 (2010-11-30),
3. 6552014 - Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors (2003-04-22),
4. 6245782 - Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors (2001-06-12),
5. 6230713 - Determining a treatment plan for patients undergoing thrombotic event by monitoring P-selectin (2001-05-15),

Title: Victor L. Serebruany: Innovator in Vascular Event Treatment

Introduction

Victor L. Serebruany is a prominent inventor based in Ellicott City, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of vascular events. With a total of 5 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on treating vascular events with statins by inhibiting PAR-1 and PAR-4. This invention relates to new methods for treating and/or preventing vascular events through the inhibition of G-coupled Protease Activating Receptor (PAR)-1 and/or PAR-4 with the administration of statins. In one embodiment, individuals at risk for vascular events, but with cholesterol levels in normal ranges, are treated with statins.

Career Highlights

Throughout his career, Victor has worked with various organizations, including Heartdrug Research, L.L.C. His innovative approaches have garnered attention in the medical community, leading to advancements in treatment methodologies.

Collaborations

Victor has collaborated with notable professionals in his field, including Paul A. Gurbel and Christopher M. O'Connor. These partnerships have further enhanced his research and development efforts.

Conclusion

Victor L. Serebruany's contributions to the treatment of vascular events through innovative methods highlight his role as a key inventor in the medical field. His work continues to pave the way for advancements in patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…